High-dose oral cholecalciferol (vitamin D3) supplementation significantly reduces evidence of disease activity in patients with clinically isolated syndrome (CIS), results of a randomized, controlled trial suggest. In addition, cholecalciferol had a favorable safety profile and was well tolerated.
High-Dose%20Vitamin%20D%20Linked%20to%20Lower%20Disease%20Activity%20in%20CIS&body=mdedge.com/neurology/articl...